The goal of this clinical trial is to evaluate the safety and efficacy of Formaderm (hyaluronic acid) dermal filler injection for soft tissue augmentation. The main questions it aims to answer are: * The differences of Wrinkle Severity Rating Scale (WSRS) after the injection. * The differences of Global Aesthetic Improvement Scale (GAIS) after the injection. * The subjective satisfaction of treatment. * Safety Indicators of which incidences on the day of the injection or after the injection. Participants will be self-controlled and randomized for same period * received both trial product and control product at the same time. * re-visited on week 2, 4, 12, 24, 36, and 52 after injection. Researchers will compare if the test product is non-inferiority to Q-Med Restylane.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
WSRS improvement ratio at week 24 post-injection
Timeframe: Baseline and week 24